Literature DB >> 12607061

Minimum number of lymph nodes that should be examined for the International Union Against Cancer/American Joint Committee on Cancer TNM classification of gastric carcinoma.

Takashi Ichikura1, Toshiya Ogawa, Kentaro Chochi, Toshinobu Kawabata, Hidekazu Sugasawa, Hidetaka Mochizuki.   

Abstract

The classification of lymph node metastasis based on the number of positive nodes has been adopted in the International Union Against Cancer/American Joint Committee on Cancer (UICC/AJCC) TNM classification of gastric carcinoma. However, the N classification (for condition of the regional lymph nodes) would be underestimated when the number of examined nodes were too small. To determine the minimum number of lymph nodes to examine for a correct classification, we analyzed 926 patients undergoing curative resection for gastric carcinoma. The number of metastatic lymph nodes correlated significantly with the number of examined lymph nodes. The pN0 patients with 10 to 14 examined nodes showed a significantly higher survival rate than did those with 5 to 9 examined nodes, and they had as good a prognosis as those with 15 or more examined nodes. In the pN1 and pN2 categories, patients with 29 or fewer examined nodes tended toward lower survival rates than did patients with 30 or more examined nodes. Among the patients who were classified as stage IA, the survival rate for those with 5 to 9 examined nodes was significantly lower than that for patients with 30 or more examined nodes. Among the patients classified as stage III, those with 10 to 19 examined nodes and those with 20 to 29 examined nodes had lower survival rates than did patients with 30 or more examined nodes. In conclusion, the minimum number of lymph nodes examined for a correct pN0 classification can be reduced from 15 to 10. For pN1-3 classifications, 20 or more nodes should be examined, and examining 30 or more lymph nodes may be desirable.

Entities:  

Mesh:

Year:  2003        PMID: 12607061     DOI: 10.1007/s00268-002-6730-9

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  23 in total

1.  Usefulness of the log odds of positive lymph nodes to predict and discriminate prognosis in gastric carcinomas.

Authors:  A Calero; J Escrig-Sos; F Mingol; A Arroyo; D Martinez-Ramos; M de Juan; J L Salvador-Sanchis; E Garcia-Granero; R Calpena; F J Lacueva
Journal:  J Gastrointest Surg       Date:  2015-01-06       Impact factor: 3.452

2.  Superiority of log odds of positive lymph nodes (LODDS) for prognostic prediction after gastric cancer surgery: a multi-institutional analysis of 7620 patients in China.

Authors:  Pengfei Gu; Jingyu Deng; Zhe Sun; Zhenning Wang; Wei Wang; Han Liang; Huimian Xu; Zhiwei Zhou
Journal:  Surg Today       Date:  2020-08-04       Impact factor: 2.549

3.  Receptor-binding cancer antigen expressed on SiSo cells can be detected in metastatic lymph nodes from gastrointestinal cancers.

Authors:  Kawin Leelawat; Surang Engprasert; Supathip Tujinda; Cheepsumon Suthippintawong; Munechika Enjoji; Manabu Nakashima; Takeshi Watanabe; Vijittra Leardkamolkarn
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

4.  Invasive intraductal papillary mucinous carcinomas of the pancreas: predictors of survival and the role of lymph node ratio.

Authors:  Stefano Partelli; Carlos Fernandez-Del Castillo; Claudio Bassi; William Mantovani; Sarah P Thayer; Stefano Crippa; Cristina R Ferrone; Massimo Falconi; Paolo Pederzoli; Andrew L Warshaw; Roberto Salvia
Journal:  Ann Surg       Date:  2010-03       Impact factor: 12.969

5.  Report from the 17th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Edmonton, Alberta; 11-12 September 2015.

Authors:  K E Mulder; S Ahmed; J D Davies; C M Doll; S Dowden; S Gill; V Gordon; P Hebbard; H Lim; A McFadden; J P McGhie; J Park; R Wong
Journal:  Curr Oncol       Date:  2016-12-21       Impact factor: 3.677

6.  Lymph node ratio and preoperative CA 19-9 levels predict overall survival and recurrence-free survival in patients with resected pancreatic adenocarcinoma.

Authors:  Sabrina C Wentz; Zhi-Guo Zhao; Yu Shyr; Chan-Juan Shi; Nipun B Merchant; Kay Washington; Fen Xia; A Bapsi Chakravarthy
Journal:  World J Gastrointest Oncol       Date:  2012-10-15

7.  N stages of the seventh edition of TNM Classification are the most intensive variables for predictions of the overall survival of gastric cancer patients who underwent limited lymphadenectomy.

Authors:  Jingyu Deng; Rupeng Zhang; Yuan Pan; Baogui Wang; Liangliang Wu; Xishan Hao; Han Liang
Journal:  Tumour Biol       Date:  2013-11-29

Review 8.  Clinical significance of lymph node metastasis in gastric cancer.

Authors:  Jing-Yu Deng; Han Liang
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

9.  Surgeons' knowledge of quality indicators for gastric cancer surgery.

Authors:  Lucy K Helyer; Catherine O'Brien; Natalie G Coburn; Carol J Swallow
Journal:  Gastric Cancer       Date:  2007-12-25       Impact factor: 7.370

10.  Factors influencing lymph node recovery from the operative specimen after gastrectomy for gastric adenocarcinoma.

Authors:  Scott J Schoenleber; Thomas Schnelldorfer; Christina M Wood; Rui Qin; Michael G Sarr; John H Donohue
Journal:  J Gastrointest Surg       Date:  2009-04-15       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.